Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine

8Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recently, an important topic of breast cancer had been published in 2013. In this report, estrogen receptor (ESR1) had defined the relation of hormone-cause breast cancer. The screening of traditional Chinese medicine (TCM) database has found the molecular compounds by simulating molecular docking and molecular dynamics to regulate ESR1. S-Allylmercaptocysteine and 5-hydroxy-L-tryptophan are selected according to the highest docking score than that of other TCM compounds and Raloxifene (control). The simulation from molecular dynamics is helpful in analyzing and detecting the protein-ligand interactions. After a comparing the control and the Apo form, then based on the docking poses, hydrophobic interactions, hydrogen bond and structure variations, this research postulates that S-allylmercaptocysteine may be more appropriate than other compounds for protein-ligand interaction. © 2014 Tzu-Chieh Hung et al.

Cite

CITATION STYLE

APA

Hung, T. C., Lee, W. Y., Chen, K. B., Chan, Y. C., & Chen, C. Y. C. (2014). Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicine. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/321486

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free